CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report (2001)

Chapter: 2. Interim Findings and Recommendations

Previous Chapter: 1. Introduction and Background
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 21
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 22
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 23
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 24
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 25
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 26
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 27
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 28
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 29
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 30
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 31
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 32
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 33
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 34
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 35
Suggested Citation: "2. Interim Findings and Recommendations." Institute of Medicine. 2001. CDC Anthrax Vaccine Safety & Efficacy Research Program: Interim Report. Washington, DC: The National Academies Press. doi: 10.17226/10157.
Page 36
Next Chapter: References
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.